Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors

被引：26

作者：

Cheng, Xian-Chao ^{[1
]}

Wang, Qiang ^{[1
]}

Fang, Hao ^{[1
]}

Tang, Wei ^{[2
]}

Xu, Wen-Fang ^{[1
]}

机构：

[1] Shandong Univ, Inst Med Chem, Sch Pharmaceut Sci, Jinan 250012, Peoples R China

[2] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Dept Surg, Grad Sch Med, Tokyo 1138655, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2008年 / 16卷 / 10期

基金：

国家高技术研究发展计划(863计划);

关键词：

sulfonyl pyrrolidine derivatives; synthesis; MMP-2; inhibitors; IC50;

D O I：

10.1016/j.bmc.2008.04.027

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of novel sulfonyl pyrrolidine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. Compounds 6a-d were more potent MMP-2 inhibitors than the positive control LY52. The structure-activity relationships were also briefly discussed. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：5398 / 5404

页数：7

共 18 条

[11] THE ORIGIN OF MATRIX METALLOPROTEINASES AND THEIR FAMILIAL RELATIONSHIPS [J].

MURPHY, GJP ;

MURPHY, G ;

REYNOLDS, JJ .

FEBS LETTERS, 1991, 289 (01) :4-7

[12] Structure and function of matrix metalloproteinases and TIMPs [J].

Nagase, H ;

Visse, R ;

Murphy, G .

CARDIOVASCULAR RESEARCH, 2006, 69 (03) :562-573

[13] Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines [J].

Natchus, MG ;

Bookland, RG ;

De, B ;

Almstead, NG ;

Pikul, S ;

Janusz, MJ ;

Heitmeyer, SA ;

Hookfin, EB ;

Hsieh, LC ;

Dowty, ME ;

Dietsch, CR ;

Patel, VS ;

Garver, SM ;

Gu, F ;

Pokross, ME ;

Mieling, GE ;

Baker, TR ;

Foltz, DJ ;

Peng, SX ;

Bornes, DM ;

Strojnowski, MJ ;

Taiwo, YO .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) :4948-4963

[14] Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases [J].

Pikul, S ;

Dunham, KLM ;

Almstead, NG ;

De, B ;

Natchus, MG ;

Anastasio, MV ;

McPhail, SJ ;

Snider, CE ;

Taiwo, YO ;

Chen, LY ;

Dunaway, CM ;

Gu, F ;

Mieling, GE .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (01) :87-94

[15] Tumour invasion and matrix metalloproteinases [J].

Polette, M ;

Nawrocki-Raby, B ;

Gilles, C ;

Clavel, C ;

Birembaut, P .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 49 (03) :179-186

[16]

Qu XJ, 2006, ANTICANCER RES, V26, P3573

[17] SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - N-(MERCAPTOACYL)-4-SUBSTITUTED-(S)-PROLINES [J].

SMITH, EM ;

SWISS, GF ;

NEUSTADT, BR ;

GOLD, EH ;

SOMMER, JA ;

BROWN, AD ;

CHIU, PJS ;

MORAN, R ;

SYBERTZ, EJ ;

BAUM, T .

JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (04) :875-885

[18] Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs [J].

Verma, Rajeshwar P. ;

Hansch, Corwin .

BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (06) :2223-2268

← 1 2 →